Literature DB >> 8193507

Dietary modifications versus dicyclomine hydrochloride in the treatment of severe infantile colics.

R Oggero1, G Garbo, F Savino, M Mostert.   

Abstract

This study examined 120 infants, aged 3-12 weeks, with severe colics and compared the results of a specific hypoallergenic diet (group A) with those of pharmacological treatment (group B). Non-breast-fed group A infants received soy milk and if unresponsive, hydrolyzed milk formulas; mothers of breast-fed infants received a diet without cow's milk, eggs or fish. Breast-fed and non-breast-fed group B infants received dicyclomine hydrochloride 3 mg/kg/day. Results, based on quantitative measurements of crying, indicated that in breast-fed infants there was no significant improvement between group A (62.5%) and group B (66.6%) infants. Among formula-fed infants, comparison of positive results using soy milk (65.9%) with positive results using dicyclomine (53.3%) was not significant; positive results using soy milk and hydrolyzed milk formulas in non-responders to soy milk, provided an improvement in 95.4% of cases. Pharmacological treatment provided an improvement in 53.3% of cases. The difference was significant (p < 0.01).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193507     DOI: 10.1111/j.1651-2227.1994.tb13055.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  11 in total

1.  Effectiveness of treatments for infantile colic: systematic review.

Authors:  P L Lucassen; W J Assendelft; J W Gubbels; J T van Eijk; W J van Geldrop; A K Neven
Journal:  BMJ       Date:  1998-05-23

Review 2.  Dietary management of infantile colic: a systematic review.

Authors:  Marina Iacovou; Robin A Ralston; Jane Muir; Karen Z Walker; Helen Truby
Journal:  Matern Child Health J       Date:  2012-08

3.  "Something is wrong with your milk": Qualitative study of maternal dietary restriction and beliefs about infant colic.

Authors:  Monica Kidd; Melanie Hnatiuk; Jocelyn Barber; Mary-Jo Woolgar; Maria Palacios Mackay
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

Review 4.  Pain-relieving agents for infantile colic.

Authors:  Elena Biagioli; Valentina Tarasco; Carla Lingua; Lorenzo Moja; Francesco Savino
Journal:  Cochrane Database Syst Rev       Date:  2016-09-16

Review 5.  Soy formula for prevention of allergy and food intolerance in infants.

Authors:  D A Osborn; J Sinn
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.

Authors:  Cara J Westmark
Journal:  Front Nutr       Date:  2017-01-18

Review 7.  The Effect of Probiotics on Symptoms, Gut Microbiota and Inflammatory Markers in Infantile Colic: A Systematic Review, Meta-Analysis and Meta-Regression of Randomized Controlled Trials.

Authors:  Karolina Skonieczna-Żydecka; Katarzyna Janda; Mariusz Kaczmarczyk; Wojciech Marlicz; Igor Łoniewski; Beata Łoniewska
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

8.  Dietary modifications for infantile colic.

Authors:  Morris Gordon; Elena Biagioli; Miriam Sorrenti; Carla Lingua; Lorenzo Moja; Shel Sc Banks; Simone Ceratto; Francesco Savino
Journal:  Cochrane Database Syst Rev       Date:  2018-10-10

Review 9.  Pharmacological interventions on early functional gastrointestinal disorders.

Authors:  Silvia Salvatore; Salvatore Barberi; Osvaldo Borrelli; Annamaria Castellazzi; Dora Di Mauro; Giuseppe Di Mauro; Mattia Doria; Ruggiero Francavilla; Massimo Landi; Alberto Martelli; Vito Leonardo Miniello; Giovanni Simeone; Elvira Verduci; Carmen Verga; Maria Assunta Zanetti; Annamaria Staiano
Journal:  Ital J Pediatr       Date:  2016-07-16       Impact factor: 2.638

Review 10.  Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis.

Authors:  Pedro Gutiérrez-Castrellón; Flavia Indrio; Alexis Bolio-Galvis; Carlos Jiménez-Gutiérrez; Irma Jimenez-Escobar; Gabriel López-Velázquez
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.